GSK plc Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2013-06-12: Form 6-K; Period of report 2013-06-12; Description DIRECTOR/PDMR SHAREHOLDING; Document gsk201306126k1.htm.
- 2013-06-12: Form 6-K; Period of report 2013-06-12; Description DIRECTOR/PDMR SHAREHOLDING; Document gsk201306126k.htm.
- 2013-06-11: Form 6-K; Period of report 2013-06-10; Description TRANSACTION IN OWN SHARES; Document gsk201306116k.htm.
- 2013-06-10: Form 6-K; Period of report 2013-06-10; Description DIRECTOR/PDMR SHAREHOLDING; Document gsk201306106k.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2013-06-12 | 6-K | 2013-06-12 | DIRECTOR/PDMR SHAREHOLDING | gsk201306126k1.htm |
| 2013-06-12 | 6-K | 2013-06-12 | DIRECTOR/PDMR SHAREHOLDING | gsk201306126k.htm |
| 2013-06-11 | 6-K | 2013-06-10 | TRANSACTION IN OWN SHARES | gsk201306116k.htm |
| 2013-06-10 | 6-K | 2013-06-10 | DIRECTOR/PDMR SHAREHOLDING | gsk201306106k.htm |
| 2013-06-07 | 6-K | 2013-06-07 | TRANSACTION IN OWN SHARES | gsk201306076k.htm |
| 2013-06-06 | 6-K | 2013-06-06 | TRANSACTION IN OWN SHARES | gsk201306066k.htm |
| 2013-06-05 | 6-K | 2013-06-03 | TRANSACTION IN OWN SHARES | gsk201306056k3.htm |
| 2013-06-05 | 6-K | 2013-06-03 | DIRECTOR/PDMR SHAREHOLDING | gsk201306056k2.htm |
| 2013-06-05 | 6-K | 2013-06-05 | DIRECTOR/PDMR SHAREHOLDING | gsk201306056k.htm |
| 2013-06-04 | 6-K | 2013-06-04 | TRANSACTION IN OWN SHARES | gsk201306046k.htm |
| 2013-06-03 | 6-K | 2013-06-03 | TRANSACTION IN OWN SHARES | gsk201306036k1.htm |
| 2013-06-03 | 6-K | 2013-06-03 | TOTAL VOTING RIGHTS | gsk201306036k.htm |
| 2013-05-31 | 6-K | 2013-05-31 | TRANSACTION IN OWN SHARES | gsk201305316k.htm |
| 2013-05-30 | 6-K | 2013-05-30 | TRANSACTION IN OWN SHARES | gsk201305306k.htm |
| 2013-05-29 | 6-K | 2013-05-29 | TRANSACTION IN OWN SHARES | gsk201305296k.htm |
| 2013-05-28 | 6-K | 2013-05-28 | TRANSACTION IN OWN SHARES | gsk201305286k1.htm |
| 2013-05-28 | 6-K | 2013-05-28 | DIRECTOR/PDMR SHAREHOLDING | gsk201305286k.htm |
| 2013-05-24 | 6-K | 2013-05-24 | TRANSACTION IN OWN SHARES | gsk201305246k.htm |
| 2013-05-23 | 6-K | 2013-05-23 | TRANSACTION IN OWN SHARES | gsk201305236k.htm |
| 2013-05-21 | 6-K | 2013-05-21 | TRANSACTION IN OWN SHARES | gsk201305216k.htm |
| 2013-05-20 | 6-K | 2013-05-20 | TRANSACTION IN OWN SHARES | gsk201305206k.htm |
| 2013-05-17 | 6-K | 2013-05-17 | TRANSACTION IN OWN SHARES | gsk201305176k1.htm |
| 2013-05-17 | 6-K | 2013-05-17 | DIRECTOR/PDMR SHAREHOLDING | gsk201305166k3.htm |
| 2013-05-17 | 6-K | 2013-05-17 | DIRECTOR/PDMR SHAREHOLDING | gsk201305176k2.htm |
| 2013-05-17 | 6-K | 2013-05-17 | BLOCKLISTING INTERIM REVIEW | gsk201305176k.htm |
| 2013-05-16 | 6-K | 2013-05-16 | DIRECTOR/PDMR SHAREHOLDING | gsk201305166k.htm |
| 2013-05-15 | 6-K | 2013-05-15 | DIRECTOR/PDMR SHAREHOLDING | gsk201305156k2.htm |
| 2013-05-15 | 6-K | 2013-05-15 | TRANSACTION IN OWN SHARES | gsk201305156k.htm |
| 2013-05-14 | 6-K | 2013-05-14 | DIRECTOR/PDMR SHAREHOLDING | gsk201305146k1.htm |
| 2013-05-14 | 6-K | 2013-05-14 | TRANSACTION IN OWN SHARES | gsk201305146k.htm |
| 2013-05-13 | 6-K | 2013-05-13 | TRANSACTION IN OWN SHARES | gsk201305136k4.htm |
| 2013-05-13 | 6-K | 2013-05-13 | DIRECTOR/PDMR SHAREHOLDING | gsk201305136k2.htm |
| 2013-05-13 | 6-K | 2013-05-13 | DIRECTOR/PDMR SHAREHOLDING | gsk201305136k3.htm |
| 2013-05-13 | 6-K | 2013-05-13 | DIRECTOR/PDMR SHAREHOLDING | gsk201305136k.htm |
| 2013-05-13 | 6-K | 2013-05-13 | DOC RE. (AGM STATEMENT) | gsk201305136k1.htm |
| 2013-05-10 | 6-K | 2013-05-10 | DIRECTOR/PDMR SHAREHOLDING | gsk201305106k2.htm |
| 2013-05-10 | 6-K | 2013-05-10 | BREO ELLIPTA FDA APPROVAL | gsk201305106k.htm |
| 2013-05-08 | 6-K | 2013-05-08 | DIRECTOR/PDMR SHAREHOLDING | gsk201305086k2.htm |
| 2013-05-08 | 6-K | 2013-05-08 | ADDITIONAL LISTING | gsk201305086k.htm |
| 2013-05-07 | 6-K | 2013-05-07 | DIRECTOR/PDMR SHAREHOLDING | gsk201305076k.htm |
| 2013-05-02 | 6-K | 2013-05-02 | CORPORATE RESPONSIBILITY COMMITTEE MEMBER CHANGE | gsk201305026k.htm |
| 2013-05-01 | 6-K | 2013-05-01 | RESULT OF AGM | gsk201305016k2.htm |
| 2013-05-01 | 6-K | 2013-04-30 | TOTAL VOTING RIGHTS | gsk201304306k1.htm |
| 2013-04-30 | 6-K | 2013-04-30 | UMEC US REGULATORY SUBMISSION | gsk201304306k.htm |
| 2013-04-29 | 6-K | 2013-04-29 | DIRECTOR/PDMR SHAREHOLDING | gsk201304296k1.htm |
| 2013-04-29 | 6-K | 2013-04-29 | DIRECTOR/PDMR SHAREHOLDING | gsk201304296k.htm |
| 2013-04-26 | 6-K | 2013-04-26 | UMEC EU REGULATORY SUBMISSION | gsk201304266k.htm |
| 2013-04-25 | 6-K | 2013-04-25 | DIRECTOR/PDMR SHAREHOLDING | gsk201304256k.htm |
| 2013-04-24 | 6-K | 2013-04-24 | 1ST QUARTER RESULTS | gsk201304246k.htm |
| 2013-04-19 | 6-K | 2013-04-19 | DIRECTOR/PDMR SHAREHOLDING | gsk201304196k4.htm |
| 2013-04-19 | 6-K | 2013-04-19 | DIRECTOR/PDMR SHAREHOLDING | gsk201304196k3.htm |
| 2013-04-19 | 6-K | 2013-04-19 | DIRECTOR/PDMR SHAREHOLDING | gsk201304196k2.htm |
| 2013-04-19 | 6-K | 2013-04-19 | DIRECTOR/PDMR SHAREHOLDING | gsk201304196k.htm |
| 2013-04-18 | 6-K | 2013-04-17 | BREO ELLIPTA FDA ADCOM VOTE | gsk201304176k6.htm |
| 2013-04-17 | 6-K | 2013-04-17 | DIRECTOR/PDMR SHAREHOLDING | gsk201304176k5.htm |
| 2013-04-17 | 6-K | 2013-04-17 | DIRECTOR/PDMR SHAREHOLDING | gsk201304176k4.htm |
| 2013-04-17 | 6-K | 2013-04-17 | DIRECTOR/PDMR SHAREHOLDING | gsk201304176k.htm |
| 2013-04-17 | 6-K | 2013-04-17 | DIRECTOR/PDMR SHAREHOLDING | gsk201304176k3.htm |
| 2013-04-17 | 6-K | 2013-04-17 | DIRECTOR/PDMR SHAREHOLDING | gsk201304176k2.htm |
| 2013-04-16 | 6-K | 2013-04-16 | DIRECTOR/PDMR SHAREHOLDING | gsk201304166k.htm |
| 2013-04-15 | 6-K | 2013-04-15 | DIRECTOR/PDMR SHAREHOLDING | gsk201304156k2.htm |
| 2013-04-15 | 6-K | 2013-04-15 | DIRECTOR/PDMR SHAREHOLDING | gsk201304156k1.htm |
| 2013-04-15 | 6-K | 2013-04-15 | DIRECTOR/PDMR SHAREHOLDING | gsk201304156k.htm |
| 2013-04-12 | 6-K | 2013-04-12 | DIRECTOR/PDMR SHAREHOLDING | gsk201304126k1.htm |
| 2013-04-12 | 6-K | 2013-04-12 | DIRECTOR/PDMR SHAREHOLDING | gsk201304126k.htm |
| 2013-04-11 | 6-K | 2013-04-11 | DIRECTOR/PDMR SHAREHOLDING | gsk201304116k1.htm |
| 2013-04-11 | 6-K | 2013-04-11 | DIRECTOR/PDMR SHAREHOLDING | gsk201304116k.htm |
| 2013-04-04 | 6-K | 2013-04-04 | DIRECTOR/PDMR SHAREHOLDING | gsk201304046k2.htm |
| 2013-04-04 | 6-K | 2013-04-04 | ADDITIONAL LISTING | gsk201304046k.htm |
| 2013-04-02 | 6-K | 2013-04-02 | DIRECTORATE CHANGE | gsk201304026k1.htm |
| 2013-04-02 | 6-K | 2013-04-02 | TOTAL VOTING RIGHTS | gsk201304026k.htm |
| 2013-03-28 | 6-K | 2013-03-28 | DIRECTOR/PDMR SHAREHOLDING | gsk201303286k.htm |
| 2013-03-27 | 6-K | 2013-03-27 | TRANSACTION IN OWN SHARES | gsk201303276k.htm |
| 2013-03-26 | 6-K | 2013-03-26 | TRANSACTION IN OWN SHARES | gsk201303266k.htm |
| 2013-03-25 | 6-K | 2013-03-25 | TRANSACTION IN OWN SHARES | gsk201303256k2.htm |
| 2013-03-25 | 6-K | 2013-03-25 | DIRECTOR/PDMR SHAREHOLDING | gsk201303256k1.htm |
| 2013-03-25 | 6-K | 2013-03-25 | DIRECTOR/PDMR SHAREHOLDING | gsk201303256k.htm |
| 2013-03-22 | 6-K | 2013-03-22 | TRANSACTION IN OWN SHARES | gsk201303226k.htm |
| 2013-03-21 | 6-K | 2013-03-21 | TRANSACTION IN OWN SHARES | gsk201303216k.htm |
| 2013-03-20 | 6-K | 2013-03-19 | DIRECTOR/PDMR SHAREHOLDING | gsk201303196k.htm |
| 2013-03-18 | 6-K | 2013-03-18 | FORM 6-K | d503486d6k.htm |
| 2013-03-18 | 6-K | 2013-03-18 | DIRECTOR/PDMR SHAREHOLDING | gsk201303186k4.htm |
| 2013-03-18 | 6-K | 2013-03-18 | TRANSACTION IN OWN SHARES | gsk201303186k3.htm |
| 2013-03-18 | 6-K | 2013-03-18 | DIRECTOR/PDMR SHAREHOLDING | gsk201303186k2.htm |
| 2013-03-18 | 6-K | 2013-03-18 | DIRECTOR/PDMR SHAREHOLDING | gsk201303186k1.htm |
| 2013-03-18 | 6-K | 2013-03-18 | DIRECTOR/PDMR SHAREHOLDING | gsk201303186k.htm |
| 2013-03-15 | 6-K | 2013-03-15 | TRANSACTION IN OWN SHARES | gsk201303156k.htm |
| 2013-03-14 | 6-K | 2013-03-14 | TRANSACTION IN OWN SHARES | gsk201303146k.htm |
| 2013-03-13 | 6-K | 2013-03-13 | FORM 6-K | d501648d6k.htm |
| 2013-03-13 | 6-K | 2013-03-13 | TRANSACTION IN OWN SHARES | gsk201303136k.htm |
| 2013-03-12 | 6-K | 2013-03-12 | TRANSACTION IN OWN SHARES | gsk201303126k2.htm |
| 2013-03-12 | 6-K | 2013-03-12 | DIRECTOR/PDMR SHAREHOLDING | gsk201303126k1.htm |
| 2013-03-12 | 6-K | 2013-03-12 | DIRECTOR/PDMR SHAREHOLDING | gsk201303126k.htm |
| 2013-03-11 | 6-K | 2013-03-11 | TRANSACTION IN OWN SHARES | gsk201303116k1.htm |
| 2013-03-11 | 6-K | 2013-03-11 | GSK FILES ITS ANNUAL REPORT 2012 ON FORM 20-F | gsk201303116k.htm |
| 2013-03-08 | 6-K | 2013-03-08 | TRANSACTION IN OWN SHARES | gsk201303086k.htm |
| 2013-03-07 | 6-K | 2013-03-07 | TRANSACTION IN OWN SHARES | gsk201303076k2.htm |
| 2013-03-07 | 6-K | 2013-03-07 | DOLUTEGRAVIR SAILING STUDY IN HIV ANNOUNCED | gsk201303076k.htm |
| 2013-03-07 | 6-K | 2013-03-07 | GSK SUBMITS ALBIGLUTIDE MAA TO THE EMA | gsk201303076k1.htm |
| 2013-03-06 | 6-K | 2013-03-06 | DIRECTOR/PDMR SHAREHOLDING | gsk201303066k1.htm |